Cervical DNA Dtex® Test
NeoDiagnostix
NeoNet »
NeoDiagnostix is a cancer diagnostics company with an emphasis in women's health. We are dedicated to providing physicians with more accurate and timely information that will lead to better patient care decisions.    >> Learn More
How It Works
The Cervical DNA Dtex Test identifies the irreversible DNA damage* to cervical cells.

> Cervical DNA Dtex Case Studies
  The Cervical DNA Dtex Test identifies the irreversible DNA damage* to cervical cells.
  


REQUEST INFORMATION

Name *  
Email *  
Phone  
Message *  
*   Fields required
News & Updates

NeoDiagnostix Inc. Announces Issuance of Third US Patent
June 12, 2014
NeoDiagnostix, Inc. announced that the United States Patent and Trademark Office has issued US Patent No. 8,748,099 covering the detection of chromosomal abnormalities in cervical samples. The patent covers methods for enumerating chromosomal copy number at location 3q, as well as other loci in the genome of cells from cervical samples.
Read More »

NeoDiagnostix Inc. Announces Issuance of US Patents
December 10, 2013
NeoDiagnostix, today announced that the United States Patent and Trademark Office has issued two US Patents covering the detection of chromosomal abnormalities in cervical samples. The patents cover methods related to both manual and automated methods for enumerating chromosomal copy number at sites 3q and 5p of the genome in cervical samples.
Read More »

NeoDiagnostix, Inc.    © 2014.    All rights reserved.     Website by Clark Concepts, LLC
NeoDiagnostix, Inc.
9 West Watkins Mill Road
Gaithersburg, MD 20878
Tel: 240-821-6000
Contact Us

References:
* as defined by multiple copies of 3q26 and/or 5p15 in cervical cells